Internal Medicine, Endocrinology, Diabetes, & Metabolism · Saint Cloud, MN
NPI
1831189240
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1900 Centracare Cir
Saint Cloud, MN, 56303
Phone (320) 229-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$174K
15,229 services
Medicare patients, 2024
463
Average age 72
Drug cost, 2024
$1.3M
2,939 prescriptions
Company payments, 2025
$46K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark D Holm was code J3111 (injection, romosozumab-aqqg, 1 mg), 7,980 times for 16 patients. In total Mark D Holm billed 15,229 services in 25 codes, and Medicare paid $174K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 7,980 | 16 | $8.58 | $68K |
| J0897 Injection, denosumab, 1 mg | Office | 2,520 | 39 | $20.63 | $52K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 264 | 64 | $23.43 | $6,185 |
| 99214 Office E&M - Established | Office | 176 | 127 | $79.22 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 155 | 134 | $12.35 | $1,914 |
| 99215 Office E&M - Established | Office | 145 | 85 | $125.84 | $18K |
| 96372 Injection Administration | Office | 98 | 59 | $10.83 | $1,061 |
| 95251 Test - Miscellaneous | Office | 96 | 42 | $25.71 | $2,468 |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 82 | 54 | $38.73 | $3,176 |
| 77080 Standard X-ray | Office | 78 | 78 | $8.95 | $698 |
| 93010 Electrocardiogram | Facility | 73 | 73 | $6.03 | $440 |
By year: 2022 $168K for 19,342 services; 2023 $153K for 16,529 services; 2024 $174K for 15,229 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark D Holm prescribed most often to Medicare patients was Levothyroxine Sodium, with 540 prescriptions and refills. In total Mark D Holm wrote 2,939 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 540 | 1,378 | 124 | $7,186 |
| Ozempic Semaglutide | 255 | 429 | 45 | $403K |
| Methimazole Generic | 186 | 492 | 51 | $2,662 |
| Pioglitazone Hcl Generic | 139 | 417 | 37 | $2,492 |
| Farxiga Dapagliflozin Propanediol | 137 | 284 | 30 | $144K |
| Atorvastatin Calcium Generic | 102 | 240 | 25 | $1,839 |
| Kerendia Finerenone | 76 | 134 | 13 | $80K |
| Hydrocortisone Generic | 74 | 130 | 17 | $3,773 |
| Metformin Hcl Er Metformin Hcl | 71 | 191 | 17 | $728 |
| Metformin Hcl Generic | 57 | 171 | 18 | $459 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 57 | 112 | 16 | $53K |
| Jardiance Empagliflozin | 56 | 145 | 15 | $80K |
| Amiloride Hcl Generic | 52 | 146 | 15 | $1,970 |
| Ramipril Generic | 45 | 83 | Under 11 | $782 |
| Spironolactone Generic | 42 | 118 | 13 | $1,025 |
Brand drugs: 1,302 claims; generic drugs: 1,492 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark D Holm $46K ($46K in general payments such as food, travel and fees) from 2 companies. The largest payer was Novo Nordisk Inc with $34K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.